RPR SONS ADVISORS PRIVATE LIMITED. P .SUNEELA RANI Jointly holding's Insider Trades & SAST Disclosures
RPR SONS ADVISORS PRIVATE LIMITED. P .SUNEELA RANI Jointly holding's most recent trade in Aurobindo Pharma Ltd. was a Pledge of 3,016,000 Equity Shares done at an average price of Rs. 828.9 . Disclosure was reported to the exchange on Dec. 21, 2020 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
RPR SONS ADVISORS PRIVATE LIMITED. P .SUNEELA RANI Jointly holding's has made SAST transactions in Aurobindo Pharma Ltd. recently where a Pledge of 2,860,000 shares done . Disclosure was reported to the exchange on July 10, 2020.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED P SUNEELA RANI Jointly holding | Promoter | Pledge | 24 Dec 2024 | 2,860,000 | 2,860,000 | - | - | 07 Jul 2020 07 Jul 2020 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED. P .SUNEELA RANI (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 220,000 | 27,516,000 | - | - | 24 Mar 2021 24 Mar 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED, P,SUNEELA RANI (Jointly holding | Promoter | Pledge | 24 Dec 2024 | 1,540,000 | 29,056,000 | - | - | 25 Mar 2021 25 Mar 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED. P.SUNEELA RANI Jointly holding | Promoter | Pledge | 24 Dec 2024 | 1,900,000 | 49,456,365 | - | - | 01 Nov 2021 01 Nov 2021 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED. P.SUNEELA RANI Jointly holding | Promoter | Pledge | 24 Dec 2024 | 600,000 | 48,856,365 | - | - | 01 Nov 2021 01 Nov 2021 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) (Re-revised) | Promoter Group | Pledge | 21 Dec 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) (Revised) | Promoter Group | Revoke | 21 Dec 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) | Promoter Group | Pledge | 12 Oct 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (Jointly holding) | Promoter Group | Pledge | 10 Jul 2020 | 2,860,000 | 196,376,250 (33.51%) | 0.49% | 778.3 | 2,225,938,000 | 07 Jul 2020 07 Jul 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.